Jacobs Levy Equity Management, Inc Harpoon Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $75,213 - $212,120	-42,255 Reduced 11.36%	329,842 $630,000
Q1 2022 May 16, 2022	BUY	$3.54 - $8.08 $160,323 - $365,935	45,289 Added 13.86%	372,097 $1.85 Million
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $1.36 Million - $1.88 Million	239,705 Added 275.2%	326,808 $2.47 Million
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $686,371 - $1.22 Million	87,103 New	87,103 $688,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $1.14 Million - $1.56 Million	-64,388 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $49,228 - $68,452	-3,837 Reduced 5.62%	64,388 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $130,512 - $219,536	11,854 Added 21.03%	68,225 $1.16 Million
Q2 2020 Aug 17, 2020	BUY	$11.11 - $24.72 $300,169 - $667,884	27,018 Added 92.05%	56,371 $936,000
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $315,251 - $479,040	29,353 New	29,353 $340,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.